James L Zehnder Selected Research

cyclic Thrombocytopenia

4/2022	Longitudinal study of 2 patients with cyclic thrombocytopenia, STAT3, and MPL mutations.
12/2020	A Blueprint for Identifying Phenotypes and Drug Targets in Complex Disorders with Empirical Dynamics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James L Zehnder Research Topics

Disease

22	Neoplasms (Cancer) 11/2022 - 01/2008
8	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2020 - 01/2004
7	Hemorrhage 01/2020 - 04/2002
6	Leukemia 10/2019 - 03/2009
6	Thrombocytopenia (Thrombopenia) 01/2019 - 01/2004
5	Thrombosis (Thrombus) 02/2021 - 04/2003
5	Lymphoma (Lymphomas) 12/2019 - 04/2015
4	Infections 01/2022 - 01/2004
4	COVID-19 01/2022 - 08/2020
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 01/2012
2	cyclic Thrombocytopenia 04/2022 - 12/2020
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 02/2021 - 08/2016
2	Mycosis Fungoides 01/2021 - 05/2010
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020 - 06/2013
2	Genetic Translocation (Chromosomal Translocation) 10/2019 - 01/2018
2	Acquired Immunodeficiency Syndrome (AIDS) 11/2018 - 01/2010
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2016 - 04/2015
2	Disease Progression 04/2015 - 07/2010
2	Residual Neoplasm 09/2014 - 01/2010
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2014 - 05/2013
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2012 - 12/2011
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 06/2012 - 05/2004
2	Blast Crisis (Blast Phase) 03/2009 - 08/2004
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2007 - 02/2004
2	Factor V Deficiency 03/2005 - 04/2002
1	Endometrial Neoplasms (Endometrial Cancer) 11/2022
1	Rare Diseases (Rare Disease) 04/2022
1	Encephalitis (Encephalitis, Rasmussen) 02/2021
1	Cerebral Infarction 02/2021
1	Exanthema (Rash) 09/2020
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 12/2019
1	Carcinoma (Carcinomatosis) 07/2019
1	Adenocarcinoma 11/2018
1	Fever (Fevers) 01/2018
1	Edema (Dropsy) 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2018
1	Eosinophilia 10/2017
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Hypoprothrombinemias (Prothrombin Deficiency) 08/2016
1	Acquired hypoprothrombinemia 08/2016
1	Hemorrhagic Disorders (Hemorrhagic Diathesis) 08/2016
1	Paraproteinemias (Monoclonal Gammopathy) 03/2016
1	Multiple Myeloma 03/2016

Drug/Important Bio-Agent (IBA)

7	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 02/2003
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2007
6	Inosine Triphosphate (ITP)IBA 01/2016 - 01/2004
5	AntibodiesIBA 02/2021 - 01/2020
5	Prothrombin (Factor II)IBA 01/2020 - 04/2003
4	Heparin (Liquaemin)FDA LinkGeneric 01/2019 - 01/2004
3	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 02/2021 - 08/2016
3	AnticoagulantsIBA 02/2021 - 09/2010
3	Pharmaceutical PreparationsIBA 01/2020 - 01/2004
3	Biological ProductsIBA 01/2020 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2013
3	Factor V (Coagulation Factor V)IBA 06/2006 - 04/2002
2	Cytidine Triphosphate (CTP)IBA 04/2022 - 01/2004
2	CytokinesIBA 01/2022 - 10/2016
2	Immunoglobulin G (IgG)IBA 12/2020 - 01/2020
2	ParaffinIBA 01/2019 - 05/2010
2	SteroidsIBA 08/2016 - 06/2013
2	Immunoglobulin M (IgM)IBA 03/2016 - 04/2015
2	factor V LeidenIBA 01/2016 - 04/2003
2	Phosphotransferases (Kinase)IBA 08/2010 - 03/2009
2	Cyclin D1IBA 03/2009 - 05/2004
2	beta CateninIBA 03/2009 - 08/2004
1	Exonucleases (3' 5' Exonuclease)IBA 11/2022
1	DNA Polymerase IIIBA 11/2022
1	Amyloid (Amyloid Fibrils)IBA 02/2021
1	Blood Proteins (Serum Proteins)IBA 01/2021
1	pembrolizumabIBA 01/2021
1	Viral RNAIBA 01/2021
1	Granzymes (Granzyme)IBA 09/2020
1	PerforinIBA 09/2020
1	Angiotensin-Converting Enzyme 2IBA 08/2020
1	Cell-Free Nucleic AcidsIBA 01/2020
1	Drug CombinationsIBA 01/2020
1	Investigational DrugsIBA 01/2020
1	eltrombopag FDA Link 01/2020
1	Immune Checkpoint InhibitorsIBA 12/2019
1	Telomerase (Telomerase Reverse Transcriptase)IBA 07/2019
1	Formaldehyde (Formol)FDA Link 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Reticulin (Reticular Fiber)IBA 01/2018
1	Transcription Activator-Like Effector NucleasesIBA 01/2018
1	ChromatinIBA 01/2018
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 10/2017
1	NucleotidesIBA 01/2017
1	Transcription Factors (Transcription Factor)IBA 10/2016
1	interferon regulatory factor-8 (interferon consensus sequence binding protein)IBA 10/2016
1	Antiphospholipid AntibodiesIBA 08/2016
1	argatroban (MPQA)FDA Link 01/2016
1	bivalirudin (Angiomax)FDA Link 01/2016

Therapy/Procedure

19	Therapeutics 01/2021 - 11/2007
3	Transplantation 10/2019 - 09/2014
2	Cell Transplantation 01/2020 - 12/2011
2	Precision Medicine 01/2020 - 01/2020
2	Aftercare (After-Treatment) 09/2014 - 12/2009
1	Ligation 01/2019